Biological tumor volume predicts survival in recurrent High-Grade glioma: A multiparametric [18F]FET PET/MRI study
European Journal of Nuclear Medicine and Molecular Imaging · 2026-01 · 53 (2) · 833-842
DOI: 10.1007/s00259-025-07469-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 24.07.2025. Verfasst von Dylan Henssen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany. dylan.henssen@medizin.uni-leipzig.de. Hauptthemen laut MEDLINE: Glioma, Positron-Emission Tomography, Tumor Burden, Magnetic Resonance Imaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and purpose Single-session, multiparametric [¹⁸F]FET PET/MRI is used to detect tumor recurrence in high-grade glioma, but its prognostic value for overall survival remains uncertain. This study evaluated whether biological tumor volume, tumor-to-background ratio (TBRmax), cerebral blood volume (rCBVmax), and choline/NAA ratio (Cho/NAA) could predict survival in recurrent high-grade glioma. Materials and methods Twenty-six patients with histopathologically confirmed tumor progression underwent simultaneous [¹⁸F]FET PET/MRI. PET-derived biological tumor volume and TBRmax, MRI-derived rCBVmax, and Cho/NAA ratio were analyzed. A Cox proportional hazards model assessed associations with overall survival, adjusting for the number of lesions and treatment strategy.
Results
Biological tumor volume (hazard ratio = 2.22, 95%-CI: 1.035–4.762, p = 0.041) and the number of lesions (hazard ratio = 1.03, 95%-CI 1.00–1.06, p = 0.036) were significantly associated with survival. TBRmax ( p = 0.089), rCBVmax ( p = 0.088), and Cho/NAA ratio ( p = 0.734) were not predictive. Treatment strategy after tumor recurrence diagnosis did not significantly impact overall-survival (HR = 0.208, p = 0.649). PET/MRI interaction terms did not enhance survival prediction.
Conclusion
Biological tumor volume is a significant prognostic imaging biomarker in recurrent high-grade glioma, emphasizing tumor burden over metabolic activity or perfusion of individual lesions. Volume-based PET metrics may offer better survival prediction than traditional PET or MRI parameters. Prospective multicenter studies are needed to validate these findings and explore automated segmentation and machine learning approaches for improved prognostication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany. dylan.henssen@medizin.uni-leipzig.de.
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands. dylan.henssen@medizin.uni-leipzig.de.
- Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany.
- Institute for Neuroradiology, University Hospital Leipzig, Leipzig, Germany.
ORCID-Profile: Dylan Henssen
Zitieren
APA
Henssen, D., Rullmann, M., Arens, A. I. J., Schildan, A., Striepe, S., Schürer, M., Scherlach, C., Jähne, K., Stassart, R., Sabri, O., Seidel, C., & Hesse, S. (2026). Biological tumor volume predicts survival in recurrent High-Grade glioma: A multiparametric [18F]FET PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging, 53(2), 833-842. https://doi.org/10.1007/s00259-025-07469-8
Vancouver
Henssen D, Rullmann M, Arens AIJ, Schildan A, Striepe S, Schürer M, et al. Biological tumor volume predicts survival in recurrent High-Grade glioma: A multiparametric [18F]FET PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(2):833-842. doi:10.1007/s00259-025-07469-8
BibTeX
@article{Henssen2026,
author = {Henssen, Dylan and Rullmann, Michael and Arens, Anne I J and Schildan, Andreas and Striepe, Stephan and Schürer, Matti and Scherlach, Cordula and Jähne, Katja and Stassart, Ruth and Sabri, Osama and Seidel, Clemens and Hesse, Swen},
title = {Biological tumor volume predicts survival in recurrent High-Grade glioma: A multiparametric [18F]FET PET/MRI study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {2},
pages = {833--842},
doi = {10.1007/s00259-025-07469-8}
}
EUVIMED